| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Athina Markou | |
| Jared W Young | |||
| P2860 | cites work | Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder | Q22241113 |
| Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. | Q24616282 | ||
| CNTRICS imaging biomarkers selection: Working memory | Q26852913 | ||
| Insensitivity to future consequences following damage to human prefrontal cortex | Q28245479 | ||
| What's better for me? Fundamental role for lateral habenula in promoting subjective decision biases | Q29397338 | ||
| Developing treatments for cognitive deficits in schizophrenia: the challenge of translation | Q30396775 | ||
| DSM-5 | Q3064664 | ||
| Dissociable contributions by prefrontal D1 and D2 receptors to risk-based decision making. | Q51864767 | ||
| Contributions of the nucleus accumbens and its subregions to different aspects of risk-based decision making. | Q51890456 | ||
| Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. | Q51935852 | ||
| Progressive ratio as a measure of reward strength. | Q52357905 | ||
| Effects of withdrawal from an escalating dose schedule of d-amphetamine on sexual behavior in the male rat. | Q52894681 | ||
| Schizophrenia | Q71121006 | ||
| Animal models of schizophrenia | Q83396618 | ||
| Measures of anhedonia and hedonic responses to sucrose in depressive and schizophrenic patients in comparison with healthy subjects | Q84447341 | ||
| Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats | Q42682244 | ||
| Inter-individual decision-making differences in the effects of cingulate, orbitofrontal, and prelimbic cortex lesions in a rat gambling task. | Q42725427 | ||
| Neurochemical modulation of response inhibition and probabilistic learning in humans | Q42794222 | ||
| MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia? | Q43178084 | ||
| Heterogeneity of strategy use in the Iowa gambling task: a comparison of win-stay/lose-shift and reinforcement learning models | Q44252271 | ||
| Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons | Q45018864 | ||
| By carrot or by stick: cognitive reinforcement learning in parkinsonism | Q45140702 | ||
| Rodent models of adaptive decision making | Q46204271 | ||
| Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release | Q46402511 | ||
| Male and female Wistar rats differ in decision-making performance in a rodent version of the Iowa Gambling Task. | Q46431416 | ||
| Effects of regional striatal lesions on motor, motivational, and executive aspects of progressive-ratio performance in rats. | Q48107552 | ||
| Nucleus accumbens dopamine depletions make rats more sensitive to high ratio requirements but do not impair primary food reinforcement | Q48161160 | ||
| Neurobiology of 50-kHz ultrasonic vocalizations in rats: electrode mapping, lesion, and pharmacology studies | Q48194030 | ||
| Risk-prone individuals prefer the wrong options on a rat version of the Iowa Gambling Task | Q48277061 | ||
| Prefrontal cortical contribution to risk-based decision making. | Q48415718 | ||
| Frontal brain asymmetry and reward responsiveness: a source-localization study. | Q48473709 | ||
| Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. | Q48567250 | ||
| Fundamental contribution by the basolateral amygdala to different forms of decision making. | Q48649010 | ||
| The good, the bad and the neutral: electrophysiological responses to feedback stimuli. | Q48679328 | ||
| Preferential involvement by nucleus accumbens shell in mediating probabilistic learning and reversal shifts. | Q50674795 | ||
| Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia | Q30413012 | ||
| Isolation rearing effects on probabilistic learning and cognitive flexibility in rats | Q30417611 | ||
| Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia | Q30428422 | ||
| Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice | Q30443234 | ||
| Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice | Q30446313 | ||
| Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia | Q30465586 | ||
| A single dose of nicotine enhances reward responsiveness in nonsmokers: implications for development of dependence | Q30482526 | ||
| Anhedonia in schizophrenia: a review of assessment strategies | Q30491345 | ||
| Decision-making impairments in the context of intact reward sensitivity in schizophrenia | Q30491830 | ||
| Sensitivity to cognitive effort mediates psychostimulant effects on a novel rodent cost/benefit decision-making task | Q30516050 | ||
| Assessment of reward responsiveness in the response bias probabilistic reward task in rats: implications for cross-species translational research | Q30543797 | ||
| Association between nicotine withdrawal and reward responsiveness in humans and rats | Q30625820 | ||
| GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders | Q30756194 | ||
| Free operant and discrete trial performance of mice in the nine-hole box apparatus: validation using amphetamine and scopolamine | Q31051073 | ||
| A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia | Q33620592 | ||
| Methodological issues in negative symptom trials | Q33804836 | ||
| Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders | Q33884990 | ||
| Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia | Q33906454 | ||
| CNTRICS final biomarker selection: Control of attention | Q33963429 | ||
| Choosing to make an effort: the role of striatum in signaling physical effort of a chosen action | Q33995329 | ||
| Animal models for the negative symptoms of schizophrenia | Q34096945 | ||
| Neonatal maternal separation exacerbates the reward-enhancing effect of acute amphetamine administration and the anhedonic effect of repeated social defeat in adult rats | Q34172647 | ||
| Increased activation in the right insula during risk-taking decision making is related to harm avoidance and neuroticism | Q34226614 | ||
| Research Domain Criteria: cognitive systems, neural circuits, and dimensions of behavior. | Q34274185 | ||
| Working memory contributions to reinforcement learning impairments in schizophrenia | Q34303262 | ||
| Fatigue in neurological disorders | Q34308653 | ||
| Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures. | Q34322992 | ||
| Amygdala-prefrontal cortical circuitry regulates effort-based decision making | Q34496984 | ||
| Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder | Q34499376 | ||
| The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia | Q34517898 | ||
| Assessment of behaviors modeling aspects of schizophrenia in Csmd1 mutant mice | Q34531704 | ||
| Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits | Q34602346 | ||
| Food and Drug Administration commentary on methodological issues in negative symptom trials | Q34604219 | ||
| Neuropsychology of reward learning and negative symptoms in schizophrenia | Q34620858 | ||
| Altered probabilistic learning and response biases in schizophrenia: behavioral evidence and neurocomputational modeling | Q34631789 | ||
| Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man | Q34649595 | ||
| The NIMH Research Domain Criteria (RDoC) Project: precision medicine for psychiatry | Q34660881 | ||
| Reward processing dysfunction in major depression, bipolar disorder and schizophrenia | Q34775751 | ||
| Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. | Q35006214 | ||
| D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex. | Q35123090 | ||
| Do GluA1 knockout mice exhibit behavioral abnormalities relevant to the negative or cognitive symptoms of schizophrenia and schizoaffective disorder? | Q35522856 | ||
| Dopamine receptor blockade attenuates the general incentive motivational effects of noncontingently delivered rewards and reward-paired cues without affecting their ability to bias action selection | Q35622661 | ||
| Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1—Psychometric Characteristics of 5 Paradigms | Q35950849 | ||
| Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2—External Validity and Correlates | Q35950856 | ||
| The relationship between reward-based learning and nicotine dependence in smokers with schizophrenia. | Q35957278 | ||
| Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction | Q36155336 | ||
| The structure of negative symptoms within schizophrenia: implications for assessment. | Q36299240 | ||
| The NIMH-MATRICS consensus statement on negative symptoms | Q36397900 | ||
| Subdomains within the negative symptoms of schizophrenia: commentary | Q36403000 | ||
| Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania | Q36510848 | ||
| Nicotinic receptors modulate transmitter cross talk in the CNS: nicotinic modulation of transmitters. | Q36694059 | ||
| Reduced reward learning predicts outcome in major depressive disorder | Q36698246 | ||
| A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia | Q36775219 | ||
| Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative | Q36881172 | ||
| Measurement issues in the use of cognitive neuroscience tasks in drug development for impaired cognition in schizophrenia: a report of the second consensus building conference of the CNTRICS initiative | Q37076386 | ||
| Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia | Q37360680 | ||
| The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology | Q37568528 | ||
| The role of the dorsal striatum and dorsal hippocampus in probabilistic and deterministic odor discrimination tasks | Q37649489 | ||
| From perception to functional outcome in schizophrenia: modeling the role of ability and motivation | Q37687029 | ||
| The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond | Q37979784 | ||
| Consideration of species differences in developing novel molecules as cognition enhancers | Q38051975 | ||
| Towards improved animal models for evaluating social cognition and its disruption in schizophrenia: the CNTRICS initiative | Q38148848 | ||
| Neural mechanisms regulating different forms of risk-related decision-making: Insights from animal models. | Q38527118 | ||
| Effort-Based Decision Making: A Novel Approach for Assessing Motivation in Schizophrenia | Q38531872 | ||
| Dissociable contributions of anterior cingulate cortex and basolateral amygdala on a rodent cost/benefit decision-making task of cognitive effort. | Q39668808 | ||
| What are the functional consequences of neurocognitive deficits in schizophrenia? | Q40976267 | ||
| Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. | Q41099297 | ||
| Pathways between early visual processing and functional outcome in schizophrenia. | Q41170667 | ||
| Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project | Q42399695 | ||
| Dopamine antagonism decreases willingness to expend physical, but not cognitive, effort: a comparison of two rodent cost/benefit decision-making tasks. | Q42556171 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 1024-34 | |
| P577 | publication date | 2015-09-01 | |
| P1433 | published in | Schizophrenia Bulletin | Q4049133 |
| P1476 | title | Translational Rodent Paradigms to Investigate Neuromechanisms Underlying Behaviors Relevant to Amotivation and Altered Reward Processing in Schizophrenia | |
| P478 | volume | 41 |
| Q47357220 | 5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice. |
| Q90431816 | Abnormal cognitive effort allocation and its association with amotivation in first-episode psychosis |
| Q38897372 | Attention and the Cholinergic System: Relevance to Schizophrenia |
| Q46193299 | Blockade of dopamine D1-family receptors attenuates the mania-like hyperactive, risk-preferring, and high motivation behavioral profile of mice with low dopamine transporter levels |
| Q42525385 | Effort-Based Decision Making in Schizophrenia: Evaluation of Paradigms to Measure Motivational Deficits |
| Q38531872 | Effort-Based Decision Making: A Novel Approach for Assessing Motivation in Schizophrenia |
| Q35950849 | Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1—Psychometric Characteristics of 5 Paradigms |
| Q35950856 | Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2—External Validity and Correlates |
| Q38976397 | Insights About Striatal Circuit Function and Schizophrenia From a Mouse Model of Dopamine D2 Receptor Upregulation |
| Q39146103 | Modelling depression in animals: at the interface of reward and stress pathways |
| Q96034363 | Open-source raspberry Pi-based operant box for translational behavioral testing in rodents |
| Q64218020 | Oxygen responses within the nucleus accumbens are associated with individual differences in effort exertion in rats |
| Q37196979 | Perseveration by NK1R-/- ('knockout') mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test. |
| Q38893899 | Preclinical Models to Investigate Mechanisms of Negative Symptoms in Schizophrenia |
| Q43892897 | Relationship between effortful motivation and neurocognition in schizophrenia |
| Q96640002 | Short-active photoperiod gestation induces psychiatry-relevant behavior in healthy mice but a resiliency to such effects are seen in mice with reduced dopamine transporter expression |
| Q97519770 | Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models |
| Q46083809 | Supplementing intensive targeted computerized cognitive training with social cognitive exercises for people with schizophrenia: An interim report |
| Q39042678 | The Five-Choice Continuous Performance Task (5C-CPT): A Cross-Species Relevant Paradigm for Assessment of Vigilance and Response Inhibition in Rodents. |
| Q46667741 | The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania |
| Q38699013 | Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies. |
Search more.